Sonia Pasi, MD
Neurology · Raleigh, NCNPI 1356425268
Payments from drug & device makers
Across 52 payments — averaging $32.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$343
- Globus Medical$175
- Abbott$151
- Alnylam Pharmaceuticals Inc.$128
- Shockwave Medical, Inc$117
- Boehringer Ingelheim$115
- plus $647 from 16 others
What the payments were for
- Food & beverage$1,676100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $343 |
| Globus Medical | 2 | $175 |
| Abbott | 9 | $151 |
| Alnylam Pharmaceuticals Inc. | 1 | $128 |
| Shockwave Medical, Inc | 1 | $117 |
| Boehringer Ingelheim | 1 | $115 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $90 |
| Biodelivery Sciences International, Inc. | 5 | $67 |
| GRT US Holding, Inc. | 1 | $58 |
| SPR Therapeutics, Inc | 2 | $56 |
| Nevro Corp. | 2 | $56 |
| Scilex Pharmaceuticals Inc. | 3 | $48 |
| Vertos Medical, Inc. | 2 | $46 |
| IBSA Pharma Inc. | 3 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Stimwave Technologies Incorporated | 2 | $35 |
| Masimo Corporation | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Nalu Medical, Inc. | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,676 in reported general payments places this provider in the 55th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl ErTramadol Hcl | 44 | $3,343 |
| Buprenorphine | 12 | $2,131 |
| Methadone Hcl | 104 | $1,760 |
| Gabapentin | 96 | $1,370 |
| Duloxetine Hcl | 84 | $1,016 |
| Tizanidine Hcl | 42 | $727 |
| Nortriptyline Hcl | 34 | $450 |
| Celecoxib | 31 | $410 |
| Cyclobenzaprine Hcl | 28 | $283 |
| Pregabalin | 25 | $219 |
| Meloxicam | 37 | $164 |
| Tramadol Hcl | 33 | $52 |
| Ropinirole Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other neurology in Raleigh
- John ScagnelliRaleigh$9.3M
- Casey JeffreysRaleigh$2.2M
- Kenneth CarnesRaleigh$1.1M
- Alvin PerkinsRaleigh$457K
- David KonancRaleigh$251K
- Michael BowmanRaleigh$223K
- Mohammad BolouriCharlotte$16.6M
- Katherine PetersDurham$11M
- T RaoCharlotte$4M
- Pramod SethiGreensboro$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.